Cardiovascular consequences of early-onset growth hormone excess

Annamaria Colao, Letizia Spinelli, Alberto Cuocolo, Stefano Spiezia, Rosario Pivonello, Carolina Di Somma, Domenico Bonaduce, Marco Salvatore, Gaetano Lombardi

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Acromegaly has relevant effects on the cardiovascular system, but few data deal with the early effects of GH and IGF-I excess. To study the early stage of acromegalic cardiomyopathy and give indirect evidence of the mechanisms underlying GH and IGF-I action on the human heart, 25 patients with uncomplicated acromegaly [15 young subjects with short-term ( ≤ 5 yr) disease and 10 with long-term ( > 5 yr) disease] and 25 sex- and age-matched controls were studied. Cardiovascular risk parameters were studied by standard methods; cardiac morphology by M-mode and Doppler echocardiography, cardiac function at rest and at peak exercise by equilibrium radionuclide angiography, and vascular disease at common carotid arteries by Doppler ultrasonography. In the patient group these measurements were repeated after 6 months of treatment with octreotide-LAR (20-40 mg, im, every 28 d). Glucose, glycosylated hemoglobin, insulin, low density lipoprotein cholesterol, triglycerides, and fibrinogen levels were higher, and high density lipoprotein cholesterol levels were lower in acromegalic patients than in controls. Resting blood pressure was similar in patients and controls, whereas heart rate at rest and systolic blood pressure at peak exercise were higher in the patients. The left ventricular mass index was higher in acromegalic patients than in controls (123.3 ± 8.9 vs. 81.5 ± 4.3 g/m 2; P <0.001); seven patients had left ventricular hypertrophy. Diastolic function was similar in the two groups. The ejection fraction at rest, but not at peak exercise, was significantly increased in the patients compared with controls. As a consequence the exercise-induced changes in the ejection fraction were lower in patients than controls (8.7 ± 1.1% vs. 21.9 ± 3.5%; P <0.001). At common carotid ultrasonography, young patients with acromegaly had increased diastolic peak velocity and increased intima media thickness, even if neither patient nor controls had atherosclerotic plaques. Six months after OCT-LAR treatment, GH and IGF-I levels remarkably decreased in all patients; 8 (53.3%) achieved disease control. Insulin, total cholesterol, and fibrinogen levels reduced, whereas high density lipoprotein cholesterol levels increased. Both at rest and at peak exercise, heart rate significantly decreased, whereas systolic and diastolic blood pressures did not change. The left ventricular mass index was significantly reduced, but it was still higher than the control value (101.6 ± 3.5 g/m 2; P <0.01). The left ventricular ejection fraction at rest was significantly reduced, but its response at peak exercise was increased (16.3 ± 2.4%), becoming similar to the control value. At common carotids, the intima media thickness of right and left arteries was significantly reduced as was the diastolic peak velocity without any change in systolic peak velocity. Short-term GH excess, despite causing enhanced cardiac performance at rest, reduces cardiac performance on effort and impairs vascular morphology. These deleterious effects of early-onset acromegaly are ameliorated by suppressing GH/IGF-I levels for 6 months.

Original languageEnglish
Pages (from-to)3097-3104
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume87
Issue number7
DOIs
Publication statusPublished - 2002

Fingerprint

Growth Hormone
Insulin-Like Growth Factor I
Acromegaly
Blood pressure
Exercise
Ultrasonography
Blood Pressure
Fibrinogen
HDL Cholesterol
Insulin
Disease control
Growth hormone excess
Echocardiography
Cardiovascular system
Angiography
Octreotide
Heart Rate
Glycosylated Hemoglobin A
Gated Blood-Pool Imaging
Radioisotopes

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Colao, A., Spinelli, L., Cuocolo, A., Spiezia, S., Pivonello, R., Somma, C. D., ... Lombardi, G. (2002). Cardiovascular consequences of early-onset growth hormone excess. Journal of Clinical Endocrinology and Metabolism, 87(7), 3097-3104. https://doi.org/10.1210/jc.87.7.3097

Cardiovascular consequences of early-onset growth hormone excess. / Colao, Annamaria; Spinelli, Letizia; Cuocolo, Alberto; Spiezia, Stefano; Pivonello, Rosario; Somma, Carolina Di; Bonaduce, Domenico; Salvatore, Marco; Lombardi, Gaetano.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 87, No. 7, 2002, p. 3097-3104.

Research output: Contribution to journalArticle

Colao, A, Spinelli, L, Cuocolo, A, Spiezia, S, Pivonello, R, Somma, CD, Bonaduce, D, Salvatore, M & Lombardi, G 2002, 'Cardiovascular consequences of early-onset growth hormone excess', Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 7, pp. 3097-3104. https://doi.org/10.1210/jc.87.7.3097
Colao, Annamaria ; Spinelli, Letizia ; Cuocolo, Alberto ; Spiezia, Stefano ; Pivonello, Rosario ; Somma, Carolina Di ; Bonaduce, Domenico ; Salvatore, Marco ; Lombardi, Gaetano. / Cardiovascular consequences of early-onset growth hormone excess. In: Journal of Clinical Endocrinology and Metabolism. 2002 ; Vol. 87, No. 7. pp. 3097-3104.
@article{fa475a0052014457955532ebe74cecb5,
title = "Cardiovascular consequences of early-onset growth hormone excess",
abstract = "Acromegaly has relevant effects on the cardiovascular system, but few data deal with the early effects of GH and IGF-I excess. To study the early stage of acromegalic cardiomyopathy and give indirect evidence of the mechanisms underlying GH and IGF-I action on the human heart, 25 patients with uncomplicated acromegaly [15 young subjects with short-term ( ≤ 5 yr) disease and 10 with long-term ( > 5 yr) disease] and 25 sex- and age-matched controls were studied. Cardiovascular risk parameters were studied by standard methods; cardiac morphology by M-mode and Doppler echocardiography, cardiac function at rest and at peak exercise by equilibrium radionuclide angiography, and vascular disease at common carotid arteries by Doppler ultrasonography. In the patient group these measurements were repeated after 6 months of treatment with octreotide-LAR (20-40 mg, im, every 28 d). Glucose, glycosylated hemoglobin, insulin, low density lipoprotein cholesterol, triglycerides, and fibrinogen levels were higher, and high density lipoprotein cholesterol levels were lower in acromegalic patients than in controls. Resting blood pressure was similar in patients and controls, whereas heart rate at rest and systolic blood pressure at peak exercise were higher in the patients. The left ventricular mass index was higher in acromegalic patients than in controls (123.3 ± 8.9 vs. 81.5 ± 4.3 g/m 2; P <0.001); seven patients had left ventricular hypertrophy. Diastolic function was similar in the two groups. The ejection fraction at rest, but not at peak exercise, was significantly increased in the patients compared with controls. As a consequence the exercise-induced changes in the ejection fraction were lower in patients than controls (8.7 ± 1.1{\%} vs. 21.9 ± 3.5{\%}; P <0.001). At common carotid ultrasonography, young patients with acromegaly had increased diastolic peak velocity and increased intima media thickness, even if neither patient nor controls had atherosclerotic plaques. Six months after OCT-LAR treatment, GH and IGF-I levels remarkably decreased in all patients; 8 (53.3{\%}) achieved disease control. Insulin, total cholesterol, and fibrinogen levels reduced, whereas high density lipoprotein cholesterol levels increased. Both at rest and at peak exercise, heart rate significantly decreased, whereas systolic and diastolic blood pressures did not change. The left ventricular mass index was significantly reduced, but it was still higher than the control value (101.6 ± 3.5 g/m 2; P <0.01). The left ventricular ejection fraction at rest was significantly reduced, but its response at peak exercise was increased (16.3 ± 2.4{\%}), becoming similar to the control value. At common carotids, the intima media thickness of right and left arteries was significantly reduced as was the diastolic peak velocity without any change in systolic peak velocity. Short-term GH excess, despite causing enhanced cardiac performance at rest, reduces cardiac performance on effort and impairs vascular morphology. These deleterious effects of early-onset acromegaly are ameliorated by suppressing GH/IGF-I levels for 6 months.",
author = "Annamaria Colao and Letizia Spinelli and Alberto Cuocolo and Stefano Spiezia and Rosario Pivonello and Somma, {Carolina Di} and Domenico Bonaduce and Marco Salvatore and Gaetano Lombardi",
year = "2002",
doi = "10.1210/jc.87.7.3097",
language = "English",
volume = "87",
pages = "3097--3104",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "7",

}

TY - JOUR

T1 - Cardiovascular consequences of early-onset growth hormone excess

AU - Colao, Annamaria

AU - Spinelli, Letizia

AU - Cuocolo, Alberto

AU - Spiezia, Stefano

AU - Pivonello, Rosario

AU - Somma, Carolina Di

AU - Bonaduce, Domenico

AU - Salvatore, Marco

AU - Lombardi, Gaetano

PY - 2002

Y1 - 2002

N2 - Acromegaly has relevant effects on the cardiovascular system, but few data deal with the early effects of GH and IGF-I excess. To study the early stage of acromegalic cardiomyopathy and give indirect evidence of the mechanisms underlying GH and IGF-I action on the human heart, 25 patients with uncomplicated acromegaly [15 young subjects with short-term ( ≤ 5 yr) disease and 10 with long-term ( > 5 yr) disease] and 25 sex- and age-matched controls were studied. Cardiovascular risk parameters were studied by standard methods; cardiac morphology by M-mode and Doppler echocardiography, cardiac function at rest and at peak exercise by equilibrium radionuclide angiography, and vascular disease at common carotid arteries by Doppler ultrasonography. In the patient group these measurements were repeated after 6 months of treatment with octreotide-LAR (20-40 mg, im, every 28 d). Glucose, glycosylated hemoglobin, insulin, low density lipoprotein cholesterol, triglycerides, and fibrinogen levels were higher, and high density lipoprotein cholesterol levels were lower in acromegalic patients than in controls. Resting blood pressure was similar in patients and controls, whereas heart rate at rest and systolic blood pressure at peak exercise were higher in the patients. The left ventricular mass index was higher in acromegalic patients than in controls (123.3 ± 8.9 vs. 81.5 ± 4.3 g/m 2; P <0.001); seven patients had left ventricular hypertrophy. Diastolic function was similar in the two groups. The ejection fraction at rest, but not at peak exercise, was significantly increased in the patients compared with controls. As a consequence the exercise-induced changes in the ejection fraction were lower in patients than controls (8.7 ± 1.1% vs. 21.9 ± 3.5%; P <0.001). At common carotid ultrasonography, young patients with acromegaly had increased diastolic peak velocity and increased intima media thickness, even if neither patient nor controls had atherosclerotic plaques. Six months after OCT-LAR treatment, GH and IGF-I levels remarkably decreased in all patients; 8 (53.3%) achieved disease control. Insulin, total cholesterol, and fibrinogen levels reduced, whereas high density lipoprotein cholesterol levels increased. Both at rest and at peak exercise, heart rate significantly decreased, whereas systolic and diastolic blood pressures did not change. The left ventricular mass index was significantly reduced, but it was still higher than the control value (101.6 ± 3.5 g/m 2; P <0.01). The left ventricular ejection fraction at rest was significantly reduced, but its response at peak exercise was increased (16.3 ± 2.4%), becoming similar to the control value. At common carotids, the intima media thickness of right and left arteries was significantly reduced as was the diastolic peak velocity without any change in systolic peak velocity. Short-term GH excess, despite causing enhanced cardiac performance at rest, reduces cardiac performance on effort and impairs vascular morphology. These deleterious effects of early-onset acromegaly are ameliorated by suppressing GH/IGF-I levels for 6 months.

AB - Acromegaly has relevant effects on the cardiovascular system, but few data deal with the early effects of GH and IGF-I excess. To study the early stage of acromegalic cardiomyopathy and give indirect evidence of the mechanisms underlying GH and IGF-I action on the human heart, 25 patients with uncomplicated acromegaly [15 young subjects with short-term ( ≤ 5 yr) disease and 10 with long-term ( > 5 yr) disease] and 25 sex- and age-matched controls were studied. Cardiovascular risk parameters were studied by standard methods; cardiac morphology by M-mode and Doppler echocardiography, cardiac function at rest and at peak exercise by equilibrium radionuclide angiography, and vascular disease at common carotid arteries by Doppler ultrasonography. In the patient group these measurements were repeated after 6 months of treatment with octreotide-LAR (20-40 mg, im, every 28 d). Glucose, glycosylated hemoglobin, insulin, low density lipoprotein cholesterol, triglycerides, and fibrinogen levels were higher, and high density lipoprotein cholesterol levels were lower in acromegalic patients than in controls. Resting blood pressure was similar in patients and controls, whereas heart rate at rest and systolic blood pressure at peak exercise were higher in the patients. The left ventricular mass index was higher in acromegalic patients than in controls (123.3 ± 8.9 vs. 81.5 ± 4.3 g/m 2; P <0.001); seven patients had left ventricular hypertrophy. Diastolic function was similar in the two groups. The ejection fraction at rest, but not at peak exercise, was significantly increased in the patients compared with controls. As a consequence the exercise-induced changes in the ejection fraction were lower in patients than controls (8.7 ± 1.1% vs. 21.9 ± 3.5%; P <0.001). At common carotid ultrasonography, young patients with acromegaly had increased diastolic peak velocity and increased intima media thickness, even if neither patient nor controls had atherosclerotic plaques. Six months after OCT-LAR treatment, GH and IGF-I levels remarkably decreased in all patients; 8 (53.3%) achieved disease control. Insulin, total cholesterol, and fibrinogen levels reduced, whereas high density lipoprotein cholesterol levels increased. Both at rest and at peak exercise, heart rate significantly decreased, whereas systolic and diastolic blood pressures did not change. The left ventricular mass index was significantly reduced, but it was still higher than the control value (101.6 ± 3.5 g/m 2; P <0.01). The left ventricular ejection fraction at rest was significantly reduced, but its response at peak exercise was increased (16.3 ± 2.4%), becoming similar to the control value. At common carotids, the intima media thickness of right and left arteries was significantly reduced as was the diastolic peak velocity without any change in systolic peak velocity. Short-term GH excess, despite causing enhanced cardiac performance at rest, reduces cardiac performance on effort and impairs vascular morphology. These deleterious effects of early-onset acromegaly are ameliorated by suppressing GH/IGF-I levels for 6 months.

UR - http://www.scopus.com/inward/record.url?scp=0036318922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036318922&partnerID=8YFLogxK

U2 - 10.1210/jc.87.7.3097

DO - 10.1210/jc.87.7.3097

M3 - Article

C2 - 12107207

AN - SCOPUS:0036318922

VL - 87

SP - 3097

EP - 3104

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 7

ER -